InnoCare Optoelectronics Corporation (TPE:6861)
Taiwan · Delayed Price · Currency is TWD 52.10
-0.70 (-1.33%)
Aug 4, 2025, 9:13 AM CST
Ligand Pharmaceuticals Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2020 |
Net Income | 175.36 | 152.94 | 116.66 | 198.72 | 198.52 | 166.03 | Upgrade |
Depreciation & Amortization | 77.32 | 79.39 | 80.41 | 69.78 | 67.89 | 59.16 | Upgrade |
Loss (Gain) From Sale of Assets | -0.17 | -0.17 | - | - | - | - | Upgrade |
Loss (Gain) From Sale of Investments | -0.01 | -0.02 | -0.01 | -0 | -0 | - | Upgrade |
Stock-Based Compensation | 0.49 | 0.95 | 21.56 | 4.79 | 10.57 | 12.94 | Upgrade |
Other Operating Activities | 17.67 | 14.99 | -19.68 | 53.14 | 7.26 | 1.22 | Upgrade |
Change in Accounts Receivable | -113.89 | -77.8 | 19.68 | -226.4 | 121.65 | -172.67 | Upgrade |
Change in Inventory | 83.77 | 59.55 | -118.06 | -67.49 | -77.59 | -148.83 | Upgrade |
Change in Accounts Payable | 30.24 | -39.6 | 85.07 | -339.23 | -557.35 | 524.41 | Upgrade |
Change in Unearned Revenue | 10.4 | -4.71 | -2.93 | 11.31 | -9.82 | 7.23 | Upgrade |
Change in Other Net Operating Assets | 37.31 | 49.42 | -73.5 | 42.14 | 112.64 | -8.7 | Upgrade |
Operating Cash Flow | 318.48 | 234.93 | 109.2 | -253.25 | -126.25 | 440.78 | Upgrade |
Operating Cash Flow Growth | - | 115.14% | - | - | - | 8.91% | Upgrade |
Capital Expenditures | -72.44 | -89.06 | -46.98 | -61.85 | -67.45 | -204.09 | Upgrade |
Sale of Property, Plant & Equipment | 48.73 | 48.73 | 1.03 | - | - | - | Upgrade |
Cash Acquisitions | - | - | - | - | -90.34 | - | Upgrade |
Sale (Purchase) of Intangibles | -1.92 | -1.92 | -14.81 | -0.81 | -0.15 | -1.86 | Upgrade |
Investment in Securities | -19.53 | -19.56 | -36.2 | 34.62 | -0.08 | - | Upgrade |
Other Investing Activities | 9.46 | 9.76 | 22.45 | 4.79 | -29.45 | -3.06 | Upgrade |
Investing Cash Flow | -35.7 | -52.03 | -74.52 | -23.25 | -187.47 | -209.01 | Upgrade |
Short-Term Debt Issued | - | 100 | - | 425 | - | - | Upgrade |
Total Debt Issued | 80 | 100 | - | 425 | - | - | Upgrade |
Short-Term Debt Repaid | - | -170 | -255 | - | - | - | Upgrade |
Long-Term Debt Repaid | - | -14.96 | -15.84 | -14.86 | -13.48 | -7.94 | Upgrade |
Total Debt Repaid | -134.58 | -184.96 | -270.84 | -14.86 | -13.48 | -7.94 | Upgrade |
Net Debt Issued (Repaid) | -54.58 | -84.96 | -270.84 | 410.14 | -13.48 | -7.94 | Upgrade |
Issuance of Common Stock | 18.06 | 18.12 | 391.97 | 11.61 | 57.78 | - | Upgrade |
Repurchase of Common Stock | - | - | - | - | - | -109.35 | Upgrade |
Common Dividends Paid | -44.29 | -44.29 | -51.2 | -38.48 | - | - | Upgrade |
Other Financing Activities | 14.11 | 24.08 | 6.94 | 8.29 | -13.91 | 39.78 | Upgrade |
Financing Cash Flow | -66.7 | -87.06 | 76.86 | 391.55 | 30.38 | -77.51 | Upgrade |
Foreign Exchange Rate Adjustments | -5.69 | 7.49 | -17.26 | 2.87 | -6.23 | 1.47 | Upgrade |
Net Cash Flow | 210.39 | 103.32 | 94.29 | 117.92 | -289.57 | 155.73 | Upgrade |
Free Cash Flow | 246.04 | 145.88 | 62.22 | -315.1 | -193.7 | 236.69 | Upgrade |
Free Cash Flow Growth | - | 134.47% | - | - | - | -38.26% | Upgrade |
Free Cash Flow Margin | 11.90% | 7.33% | 3.39% | -16.70% | -9.98% | 10.13% | Upgrade |
Free Cash Flow Per Share | 5.85 | 3.48 | 1.52 | -8.28 | -5.36 | 7.47 | Upgrade |
Cash Interest Paid | 2.35 | 2.8 | 7.2 | 5.28 | 0.8 | 0.7 | Upgrade |
Cash Income Tax Paid | - | - | - | 34.67 | 57.2 | 46.02 | Upgrade |
Levered Free Cash Flow | 98.71 | 4.04 | -19.05 | -461.81 | -424.57 | 55.32 | Upgrade |
Unlevered Free Cash Flow | 100.3 | 5.86 | -14.47 | -458.51 | -424.07 | 55.76 | Upgrade |
Change in Net Working Capital | -51.43 | 4.39 | 74.12 | 524.35 | 500.38 | -98.35 | Upgrade |
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.